Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease.
Nasimudeen R JabirChelapram K FirozFarid AhmedMohammad A KamalSalwa HindawiGhazi A DamanhouriHussein A AlmehdarShams TabrezPublished in: Immunological investigations (2017)
Current study provides an insight toward the association of immune cells and inflammation with CAD.